Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Galpharm (Ibuprofen)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Galpharm Children's Ibuprofen 100mg/5ml oral suspension
1001010J0DFACBH
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Ibuprofen For Children 100mg/5ml susp 5ml sachets
1001010J0DFAABM
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Maximum Strength Ibuprofen 400mg liquid capsules
1001010J0DFABAU
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Galpharm Migraine Relief 200mg capsules
1001010J0DFADAA
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Paramed Ibuprofen 200mg liquid capsules
1001010J0DFAEAA
|
Galpharm (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.